Neurexis Therapeutics
Neuroprotective Innovationfor Human Health Surviving a brain disorder is only half the battle. For millions of patients, long-lasting cognitive impairment reshapes daily life. This persistent damage is driven by neurodegeneration, a shared hallmark across major disorders of the central nervous system, including global cerebral ischemia, spinal cord ischemia, stroke, and Alzheimer’s disease.Despite tremendous effort, there
Private Company
Total funding raised: $5M
About
Neuroprotective Innovationfor Human Health Surviving a brain disorder is only half the battle. For millions of patients, long-lasting cognitive impairment reshapes daily life. This persistent damage is driven by neurodegeneration, a shared hallmark across major disorders of the central nervous system, including global cerebral ischemia, spinal cord ischemia, stroke, and Alzheimer’s disease.Despite tremendous effort, there